<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01311102</url>
  </required_header>
  <id_info>
    <org_study_id>13531-01</org_study_id>
    <nct_id>NCT01311102</nct_id>
  </id_info>
  <brief_title>The Impact of Pain Scores on Intrauterine Lidocaine Versus Normal Saline Infusion at the Time of IUD Placement</brief_title>
  <official_title>Double Blind, Randomized, Prospective Trial of Impact of Pain Scores on Intrauterine Lidocaine vs Normal Saline Infusion Before IUD Placement.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Women's Health Care Clinic, Torrance, California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Women's Health Care Clinic, Torrance, California</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that infusion of 2% lidocaine at the time of IUD placement will
      reduce pain scores related to that procedure. In a double blinded randomized trial of 60
      women receiving either normal saline or lidocaine infused through an endometrial aspirator,
      pain scores will be obtained for each step of the IUD placement procedure and for the total
      experience.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      IUDs are the most frequently used method of reversible birth control. The placement procedure
      is straightforward, but can cause the women cramping and pain. Every woman is advised to take
      Ibuprofen or acetaminophen prior to her appointment. Gentle techniques and distraction are
      used to minimize discomfort. However, some women still have measurable pain during and
      immediately after the procedure.

      Investigators have shown that infusion of 5cc of a 2% concentration of liquid lidocaine into
      the inside of the uterus can reduce the pain that is associated with other procedures, such
      as biopsies done of the lining of the uterus. The investigators seek to determine if a
      similar infusion made before IUD placement may reduce pain. Because pain is a subjective
      complaint and because plastic tubing is being used to sound the uterus instead of the usual
      metal probe (a uterine sound), the investigators have included a placebo arm with saline
      infusion. All women will receive oral medication in advance of IUD placement, so no woman
      will be subject to placebo only.

      Those women undergoing routine screening for IUD candidacy will be approached. Medical and
      social history and routine laboratory testing are to be done. The risks, benefits, and side
      effects of IUD placement will be explained. They will sign consent forms for the IUD from
      both the manufacturer and the clinic before evaluation for possible inclusion in this study.
      Informed consent for the study will be obtained either at that visit or on the day of the IUD
      placement. All the routine IUD placement steps will be done and she will rate the pain score.
      A standardized pain scale from 1-10, with 10 being the worst pain in the patient's lifetime,
      will be used here and at every point in the study. Depth of the uterus will be determined by
      introducing a plastic tubing into the woman's uterus. This tubing will either be filled with
      1.3cc of normal saline or 2% lidocaine. The liquid will be infused at certain points within
      the cervix and uterus. She will again be asked to rate her pain score for that procedure. The
      tubing will be removed and the IUD will be placed. After the IUD is in the correct position,
      but before removal of the tenaculum, she will again be asked to rate her pain score for that
      procedure. After the IUD placement procedure is complete and the patient is dressed, she will
      be asked to assign an overall pain score. Pain scores between placebo and study drug used
      will be compared (mean, median and range). Fisher T tests will be performed to determine
      statistical significance with the p&lt; 0.05 as a cutoff. Sub-analysis will be done comparing
      scores of which women who have never been pregnant to those who have. If possible,
      comparisons of pain scores will be made for women who have had vaginal deliveries compared to
      those who delivered by C-section. The risks to the patient for this study intervention are
      minimal.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Scores During Overall IUD Placement</measure>
    <time_frame>Before patient left the examination room at conclusion of procedure</time_frame>
    <description>Pain score on 0-9 scale obtained just before the patient left the examination room; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain During Tenaculum Placement</measure>
    <time_frame>Immediately following tenaculum placement</time_frame>
    <description>Pain score on 0-9 scale for tenaculum placement (without anesthesia); with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot; Taken to adjust for different pain thresholds among subjects</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Measurement During Liquid Infusion/Sounding</measure>
    <time_frame>Recorded at the end of the infusion</time_frame>
    <description>After liquid infused into three parts of the endometrial cavity: in the lower one third, the middle, and at the top of the cavity. Pain was scored on a 0-9 scale; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain During IUD Placement</measure>
    <time_frame>Immediately after IUD placement</time_frame>
    <description>IUD was inserted following the manufacturer's instructions, and a pain score was immediately obtained. Pain was scored on 0-9 scale; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>2% Lidocaine liquid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.33cc of 2% liquid lidocaine infused in endo cervix and endometrium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1.33cc of normal saline infused in endo cervix and endometrium</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>1.33 cc 2% liquid lidocaine</description>
    <arm_group_label>2% Lidocaine liquid</arm_group_label>
    <other_name>Lidocaine Hydrochloride</other_name>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>1.33cc normal saline</description>
    <arm_group_label>Normal Saline</arm_group_label>
    <other_name>Sodium chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women eligible for IUD insertion

          -  Willing to give consent

        Exclusion Criteria:

          -  Allergy to lidocaine

          -  Contraindications to IUD use
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anita L Nelson, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Women's Health Care Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Women's Health Care Clinic</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dogan E, Celiloglu M, Sarihan E, Demir A. Anesthetic effect of intrauterine lidocaine plus naproxen sodium in endometrial biopsy. Obstet Gynecol. 2004 Feb;103(2):347-51.</citation>
    <PMID>14754707</PMID>
  </reference>
  <reference>
    <citation>Trolice MP, Fishburne C Jr, McGrady S. Anesthetic efficacy of intrauterine lidocaine for endometrial biopsy: a randomized double-masked trial. Obstet Gynecol. 2000 Mar;95(3):345-7.</citation>
    <PMID>10711541</PMID>
  </reference>
  <reference>
    <citation>Gupta N, Ghosh B, Mittal S. Comparison of oral naproxen and intrauterine lignocaine instillation for pain relief during hysterosalpingography. Int J Gynaecol Obstet. 2008 Sep;102(3):284-6. doi: 10.1016/j.ijgo.2008.04.013. Epub 2008 Jul 7.</citation>
    <PMID>18603250</PMID>
  </reference>
  <reference>
    <citation>Lau WC, Tam WH, Lo WK, Yuen PM. A randomised double-blind placebo-controlled trial of transcervical intrauterine local anaesthesia in outpatient hysteroscopy. BJOG. 2000 May;107(5):610-3.</citation>
    <PMID>10826574</PMID>
  </reference>
  <reference>
    <citation>Guney M, Oral B, Bayhan G, Mungan T. Intrauterine lidocaine infusion for pain relief during saline solution infusion sonohysterography: a randomized, controlled trial. J Minim Invasive Gynecol. 2007 May-Jun;14(3):304-10.</citation>
    <PMID>17478360</PMID>
  </reference>
  <reference>
    <citation>Edelman A, Nichols MD, Leclair C, Jensen JT. Four percent intrauterine lidocaine infusion for pain management in first-trimester abortions. Obstet Gynecol. 2006 Feb;107(2 Pt 1):269-75.</citation>
    <PMID>16449111</PMID>
  </reference>
  <reference>
    <citation>Hui SK, Lee L, Ong C, Yu V, Ho LC. Intrauterine lignocaine as an anaesthetic during endometrial sampling: a randomised double-blind controlled trial. BJOG. 2006 Jan;113(1):53-7.</citation>
    <PMID>16398772</PMID>
  </reference>
  <reference>
    <citation>Edelman A, Nichols MD, Leclair C, Astley S, Shy K, Jensen JT. Intrauterine lidocaine infusion for pain management in first-trimester abortions. Obstet Gynecol. 2004 Jun;103(6):1267-72.</citation>
    <PMID>15172863</PMID>
  </reference>
  <reference>
    <citation>Frishman GN, Spencer PK, Weitzen S, Plosker S, Shafi F. The use of intrauterine lidocaine to minimize pain during hysterosalpingography: a randomized trial. Obstet Gynecol. 2004 Jun;103(6):1261-6.</citation>
    <PMID>15172862</PMID>
  </reference>
  <reference>
    <citation>Costello MF, Horrowitz S, Steigrad S, Saif N, Bennett M, Ekangaki A. Transcervical intrauterine topical local anesthetic at hysterosalpingography: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril. 2002 Nov;78(5):1116-22.</citation>
    <PMID>12414003</PMID>
  </reference>
  <reference>
    <citation>GÃ¼ney M, Oral B, Mungan T. Efficacy of intrauterine lidocaine for removal of a &quot;lost&quot; intrauterine device: a randomized, controlled trial. Obstet Gynecol. 2006 Jul;108(1):119-23.</citation>
    <PMID>16816065</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2010</study_first_submitted>
  <study_first_submitted_qc>March 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2011</study_first_posted>
  <results_first_submitted>October 14, 2013</results_first_submitted>
  <results_first_submitted_qc>December 17, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 5, 2014</results_first_posted>
  <last_update_submitted>December 17, 2013</last_update_submitted>
  <last_update_submitted_qc>December 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Women's Health Care Clinic, Torrance, California</investigator_affiliation>
    <investigator_full_name>Anita Nelson</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <keyword>Pain score</keyword>
  <keyword>IUD placement</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lidocaine</title>
          <description>Lidocaine : 1.33 cc of 2% liquid lidocaine</description>
        </group>
        <group group_id="P2">
          <title>Normal Saline</title>
          <description>Normal Saline : 1.33cc of normal saline</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Pilot study using a population of convenience within study location.</population>
      <group_list>
        <group group_id="B1">
          <title>Lidocaine</title>
          <description>Lidocaine : 1.33cc of 2% liquid lidocaine</description>
        </group>
        <group group_id="B2">
          <title>Normal Saline</title>
          <description>Normal Saline : 1.33cc of normal saline</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <title>Age Range</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.05" spread="Not reported" lower_limit="20" upper_limit="43"/>
                    <measurement group_id="B2" value="32.06" spread="Not reported" lower_limit="19" upper_limit="46"/>
                    <measurement group_id="B3" value="32.055" spread="Not reported" lower_limit="19" upper_limit="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Scores During Overall IUD Placement</title>
        <description>Pain score on 0-9 scale obtained just before the patient left the examination room; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
        <time_frame>Before patient left the examination room at conclusion of procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lidocaine</title>
            <description>Lidocaine : 1.33cc of 2% liquid lidocaine</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Normal Saline : 1.33cc of normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scores During Overall IUD Placement</title>
          <description>Pain score on 0-9 scale obtained just before the patient left the examination room; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
          <units>units on a scale of 0-9</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.12" spread="2.32" lower_limit="0" upper_limit="9"/>
                    <measurement group_id="O2" value="1.73" spread="1.49" lower_limit="0" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain During Tenaculum Placement</title>
        <description>Pain score on 0-9 scale for tenaculum placement (without anesthesia); with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot; Taken to adjust for different pain thresholds among subjects</description>
        <time_frame>Immediately following tenaculum placement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lidocaine</title>
            <description>Lidocaine : 1.33cc of 2% liquid lidocaine</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Normal Saline : 1.33cc of normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Pain During Tenaculum Placement</title>
          <description>Pain score on 0-9 scale for tenaculum placement (without anesthesia); with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot; Taken to adjust for different pain thresholds among subjects</description>
          <units>units on a scale of 0-9</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.20" spread="2.42"/>
                    <measurement group_id="O2" value="2.70" spread="2.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Measurement During Liquid Infusion/Sounding</title>
        <description>After liquid infused into three parts of the endometrial cavity: in the lower one third, the middle, and at the top of the cavity. Pain was scored on a 0-9 scale; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
        <time_frame>Recorded at the end of the infusion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lidocaine</title>
            <description>Lidocaine : 1.33cc of 2% liquid lidocaine</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Normal Saline : 1.33cc of normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Measurement During Liquid Infusion/Sounding</title>
          <description>After liquid infused into three parts of the endometrial cavity: in the lower one third, the middle, and at the top of the cavity. Pain was scored on a 0-9 scale; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
          <units>units on a scale of 0-9</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.50" spread="3.09"/>
                    <measurement group_id="O2" value="3.39" spread="3.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain During IUD Placement</title>
        <description>IUD was inserted following the manufacturer's instructions, and a pain score was immediately obtained. Pain was scored on 0-9 scale; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
        <time_frame>Immediately after IUD placement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lidocaine</title>
            <description>Lidocaine : 1.33cc of 2% liquid lidocaine infused in endo cervix and endometrium</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Normal Saline : 1.33cc of normal saline infused in endo cervix and endometrium.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain During IUD Placement</title>
          <description>IUD was inserted following the manufacturer's instructions, and a pain score was immediately obtained. Pain was scored on 0-9 scale; with 0 being &quot;no pain&quot; and 9 being &quot;worst pain in life.&quot;</description>
          <units>units on a scale of 0-9</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.95" spread="2.61"/>
                    <measurement group_id="O2" value="3.68" spread="2.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Lidocaine</title>
          <description>Lidocaine : 1.33cc of 2% liquid lidocaine</description>
        </group>
        <group group_id="E2">
          <title>Normal Saline</title>
          <description>Normal Saline : 1.33cc of normal saline</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This was a small pilot study, so may have missed small differences in pain score. Based on the results obtained, a sample size of 418 subjects would be needed to detect a statistically significant difference in the pain scores.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Anita Nelson</name_or_title>
      <organization>Harbor-UCLA Medical Center</organization>
      <phone>310-222-3871</phone>
      <email>anitanelsonwhc@earthlink.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

